Given that K562 was derived from chronic myeloid leukemia patient, the Bcr/Abl1 translocation present in the genetic background potentially could alter the biology of Flt3 in our findings. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.